or Try an Advanced Search...

    Cancer Treatment Stocks List

    Symbol Grade Name % Change
    PYXS C Pyxis Oncology, Inc. -3.25
    ATOS C Atossa Genetics Inc. -1.94
    ADAP C Adaptimmune Therapeutics plc -6.69
    NXTC C NextCure, Inc. -1.86
    ORIC C Oric Pharmaceuticals, Inc. -9.14
    MRKR C Marker Therapeutics, Inc. -2.89
    CLDX C Celldex Therapeutics, Inc. -6.58
    GLSI C Greenwich LifeSciences, Inc. -1.84
    RZLT C Rezolute, Inc. -1.36
    MJ C ETFMG Alternative Harvest ETF -2.41
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
    Related Stock Lists: Medicine Cancer Clinical Medicine Immunotherapy Biopharmaceutical Solid Tumors Ovarian Cancer Biotechnology Breast Cancer Immunology Monoclonal Antibody Non Small Cell Lung Cancer Small Cell Lung Cancer Treatment Of Cancer Virotherapy Acid Antibody Drug Conjugate Antineoplastic Drugs Cancer Center Cancer Immunotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Treatment stocks.

    Symbol Grade Name Weight
    FTXH A First Trust Nasdaq Pharmaceuticals ETF 6.14
    IWN B iShares Russell 2000 Value ETF 6.0
    IWM B iShares Russell 2000 ETF 6.0
    PPH A Market Vectors Pharmaceutical ETF 5.13
    IWO B iShares Russell 2000 Growth ETF 5.0
    View all Cancer Treatment ETFs...
    Compare ETFs
    Compare IWM to IWO Compare IWM to PPH Compare IWN to IWO

        Cancer Treatment Stocks Recent News

        Date Stock Title
        Aug 2 ADAP FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
        Aug 2 ADAP Adaptimmune granted FDA accelerated nod for lead asset
        Aug 2 NXTC NextCure GAAP EPS of -$0.55 misses by $0.17
        Aug 2 ADAP Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor
        Aug 1 NXTC NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
        Aug 1 GLSI Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
        Jul 31 CLDX Celldex: Latest Urticaria Data Gives Market Jitters - I'm On Sidelines
        Jul 31 RZLT Rezolute to Participate in the BTIG Virtual Biotechnology Conference
        Jul 30 CLDX Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
        Jul 29 CLDX Celldex phase 2 barzolvolimab trial in urticaria meets key endpoint, but stock slips
        Jul 29 CLDX Celldex Therapeutics Presents Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria
        Jul 29 ORIC ORIC Pharmaceuticals Stock: Too Early To Justify This Valuation
        Jul 29 PYXS Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
        Jul 28 CLDX ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
        Jul 28 CLDX Companies Like Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Invest In Growth
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Insurance - Diversified Medical Instruments & Supplies
        Related Stock Lists: Cancer Biotechnology Medicine Clinical Medicine Solid Tumors Biopharmaceutical Immune System Leukemia Antineoplastic Drugs Chimeric Antigen Receptor Epidermal Growth Factor Receptor Life Sciences Multiple Myeloma Protein Kinase Inhibitor Treatment Of Cancer Tyrosine Kinase Receptors Advanced Solid Tumors Akseli Hemminki Amines Atrial Fibrillation
        Cancer Treatment

        Cancer treatment is the use of medical therapies to treat cancer. These treatments may include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. The goal of cancer treatment is to remove or destroy the cancer cells, reduce symptoms, and improve quality of life.

        Browse All Tags